Jeffrey L. Curtis, M.D.
Professor of Internal Medicine
Division of Pulmonary & Critical Care Medicine
University of Michigan Health System
Chief, Pulmonary & Critical Care Section
Department of Veterans Affairs Health System, Ann Arbor, MI
Pulmonary & Critical Care Medicine Section
VA Health System (506/111G)
2215 Fuller Road
Ann Arbor, MI 48105-2303
(734) 845-3457
(734) 845-3257 (fax)
Jeffrey L. Curtis, M.D.
Professor of Internal Medicine
Division of Pulmonary & Critical Care Medicine
University of Michigan Health System
Chief, Pulmonary & Critical Care Section
Department of Veterans Affairs Health System, Ann Arbor, MI
Pulmonary & Critical Care Medicine Section
VA Health System (506/111G)
2215 Fuller Road
Ann Arbor, MI 48105-2303
(734) 845-3457
(734) 845-3257 (fax)
Title and ContentsPage 1
Education and TrainingPage 2
Certification and LicensurePage 2
Academic, Administrative and Clinical AppointmentsPage 3
Research InterestsPage 3
GrantsPage 3
Honors and AwardsPage 6
Memberships in Professional SocietiesPage 6
Editorial Positions, Boards and Peer-Review ServicePage 7
TeachingPage 9
Committee, Organizational, and Volunteer ServicePage 16
Consulting PositionsNA
Visiting Professorships, Seminars, and Extramural Invited PresentationsPage 18
PatentsNA
BibliographyPage 23
Jeffrey L. Curtis, M.D.
Professor of Internal Medicine
Division of Pulmonary & Critical Care Medicine
University of Michigan Health System
Chief, Pulmonary & Critical Care Section
Department of Veterans Affairs Health System, Ann Arbor, MI
Pulmonary & Critical Care Medicine Section
VA Health System (506/111G)
2215 Fuller Road
Ann Arbor, MI 48105-2303
(734) 845-3457
(734) 845-3257 (fax)
Education and Training
9/1965-6/1969Trinity High School; Shiremanstown, PA (summa cum laude)
9/1969-5/1973University of Scranton, Scranton, PA; Bachelor of Science, Biology
(magna cum laude)
9/1973-5/1977Georgetown University School of Medicine, Washington, DC;Doctor of Medicine
6/1977-6/1980 Internal Medicine Residency, Johns Hopkins Bayview Medical Center (formerly Baltimore City Hospitals), Baltimore, MD
7/1980-6/1981Chief Medical Resident, Johns Hopkins Bayview Medical Center, Baltimore, MD (Dr. Philip D. Zieve)
7/1981-6/1983Clinical Immunology fellow, Gerontology Research Center, NIH/NIA (Laboratories of Drs. William H. Adler & Albert A. Nordin); and Sarcoidosis Clinic (Dr. Carol Johns), The Johns Hopkins Hospital, Baltimore, MD
7/1983-6/1984 Postdoctoral Pulmonary Immunology Research Trainee, VA Medical Center & Cardiovascular Research Institute (CVRI), University of California San Francisco (UCSF) (Laboratory of Dr. H. Benfer Kaltreider)
7/1984-6/1985Clinical Pulmonary Fellow, Pulmonary Training Program, UCSF (Drs. John F. Murray & Jay A. Nadel)
Certification and Licensure
1979-presentFederal Drug Enforcement Administration Registration - AC9064508
2007-presentNational Provider Identifier - 1578649018
Board Certification
1980-lifetimeAmerican Board of Internal Medicine, Diplomate in Internal Medicine
1983American College of Surgeons Instructor, Advanced Trauma Life Support
1986-lifetimeAmerican Board of Internal Medicine, Diplomate in Pulmonary Diseases
1989 -1999American Board of Internal Medicine, Diplomate in Critical Care Medicine
State Licensure
1979-1991Maryland Medical Licensure - License D24373
1983-1990California Medical Licensure - License G50052
1990-presentMichigan Medical Licensure - License 4301056149
Academic, Administrative, and Clinical Appointments
Academic Appointments
7/1985-9/1988Assistant Research Immunologist, Department of Medicine, University of California, San Francisco, CA
10/1988-6/1990Assistant Professor in Residence, Department of Medicine, University of California, San Francisco, CA
7/1990-8/1996Assistant Professor, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI
9/1996-8/2002Associate Professor with tenure, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI
7/2000-presentMember, Graduate Program in Immunology, University of Michigan Health System, Ann Arbor, MI
9/2002-presentProfessor, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI
Administrative Appointments
7/1990-presentChief, Pulmonary & Critical Care Section, Department of Veterans Affairs Health System, Ann Arbor, MI
Clinical Appointments
7/1985-10/1988Attending Physician, Respiratory Care Section, Veterans Administration (VA) Medical Center, San Francisco, CA
10/1988-6/1990Staff Physician, VA Medical Center, San Francisco, CA
7/1990-presentAttending Physician, Pulmonary & Critical Care Medicine Division, UMHS, Ann Arbor, MI
7/1990-presentStaff Physician, Pulmonary & Critical Care Medicine Section, Department of Veterans Affairs Health System, Ann Arbor, MI
Research Interests
1.Regulation of pulmonary immunity, especially though control of lung lymphocyte recruitment and apoptosis, using multiple murine models of lung inflammation, auto-immunity, infection, and tobacco-smoke exposure.
2.Efferocytosis and its immunological consequences.
3.Immunopathogenesis and treatment of chronic obstructive pulmonary disease in human subjects.
4.Ontogeny, phagocytosis, and signal transduction by lung mononuclear cells (including both alveolar macrophages and dendritic cells).
Grants
Current:
NIH/NHLBI, U01 HL098961“Understanding the Lung Microbiome in HIV-Infected HIV-UninfectedIndividuals”MPIs: Jeffrey L. Curtis, M.D., James M. Beck, M.D. Vincent B. Young, M.D., Ph.D.Role: Contact Principal Investigator (25% UMHS effort, 15% total professional effort; 1.40 calendar months/year). 10/01/2009-07/31/2014 ($525,000 direct cost annually)
NIH/NHLBI, U10 HL074422
“Strategies to Prevent Chronic Obstructive Pulmonary Disease (COPD) Exacerbation” (COPD Clinical Research Network)”
P.I.: Fernando J. Martinez, M.D., M.S.
Role: Co-Investigator & VA Site P.I. (5% UMHS effort; 3% total professional effort); 10/01/2004-07/31/2013 ($1,047,083 total direct costs).
NIH/NHLBI, R01 HL089856 & R01 HL089857
“Genetic Epidemiology of COPD (COPDGene®)”
P.I.: James D. Crapo, M.D. and Edwin K. Silverman, M.D., Ph.D.
Role: Co-Investigator & VA Site P.I.; 0.24 calendar months/year.
10/31/2007-7/31/2017 (Annual Direct Funds to UMHS: $205,408).
NIH/NHLBI, Contract No. HHSN26820090016C
“Subpopulations and Intermediate Outcome Measure in COPD Study (SPIROMICS): Clinical Centers”
P.I.: Fernando J. Martinez, M.D., M.S.
Role: Co-Principal Investigator, VA site-P.I., (0.60 calendar months/year)
02/01/2009-01/31/2016 ($1,961,990 total direct costs; $$386,261 annual direct costs).
NIH/NHLBI, Contract No. HHSN2682011008C
“Lung Tissue Research Consortium (LTRC): Clinical Centers”
P.I.: Fernando J. Martinez, M.D., M.S.
Role: Project Director, Project 1: “CD8 Tc1 cells & Macrophages in COPD pathogenesis” (20% UMHS effort; 14% total professional effort; 0.60 calendar months/year).
02/01/2004-01/31/2015 ($707,779 direct annual costs).
NIH/NHLBI, Subcontract of Contract No. HHSN2682011008C
“Subpopulations and Intermediate Outcome Measure in COPD Study (SPIROMICS): Immunophenotyping Substudy”
P.I.: Jeffrey L. Curtis, M.D.
10/01/2011-09/30/2013 ($1,200.00 total direct costs; $400,000 annual direct costs).
Pending:
none
Recent:
Department of Veterans Affairs Research Enhancement Award Program (REAP) “Pulmonary Innate Immunity in the Pathogenesis of Tobacco-induced Lung Diseases” (renewal years 05-10)
P.I.: Jeffrey L. Curtis, M.D. (20% VA effort/15% total professional effort; 0.80 calendar months/year); 01/01/2005-12/31/2011 ($1,625,000 total direct costs; $250,000annual direct costs).
NIH/NHLBI,N01 HR76192
“Long-term Oxygen Treatment Trial (LOTT) – Regional Clinic Centers”
P.I.: Fernando J. Martinez, M.D., M.S.
Role: Co-Investigator & VA site-P.I. (10% UMHS effort; 7% total professional effort);10/31/2006-10/30/2012 ($179,579 annual direct costs).
NIH/NHLBI, R01 HL082480-6
“Innate and adaptive immunity in COPD exacerbations”
P.I.: Jeffrey L. Curtis, M.D. (30% UMHS effort; 20% total professional effort); 09/26/2005-07/31/2011 ($1,992,543 total direct costs).
NIH/NHLBI, R01 HL056309-13
“Apoptotic T cell Clearance from Murine Lungs” (renewal years 06-13)
P.I.: Jeffrey L. Curtis, M.D. (20% University effort/14% total professional effort); 05/01/1996-03/31/2011 ($2,268,000 total direct costs).
NIH/NIAM, R01 AT004793
“Quercetin and innate immune modulation in COPD”
P.I. Umadevi S. Sajjan, Ph.D.
Role: Co-I. (5% UMHS effort, cost-shared with VA.; 0.60 calendar months/year); 7/1/2008-6/30/2013
($1,447,681 total direct costs; $373,957 annual direct costs).
Boehringer Ingelheim Protocol 205.325
“A Randomized, Double-blind, Double-dummy, Parallel Group Trial comparing 12 weeks Treatment with Tiotropium Inhalation Capsules 18 mcg via the HandiHaler® Once Daily to Combivent® Inhalation Aerosol CFC MDI 2 Actuations q.i.d., in COPD patients currently prescribed Combivent® Inhalation Aerosol CFC MDI”.
Role: VA site-P.I. (0% UMHS effort; 0% total professional effort) 10/31/2006-9/30/2008.
Department of Veterans Affairs Merit Review Award (renewal years 14-19)
“Recruitment and Activation of Pulmonary Lymphocyte Subsets”
P.I.: Jeffrey L. Curtis, M.D. (35% VA effort; 26% total professional effort)
10/01/2002-09/30/2007 ($675,000 total direct costs)
Department of Veterans Affairs Research Enhancement Award Program “Molecular Mechanisms in Lung Host Defense”
P.I.: Jeffrey L. Curtis, M.D. (20% effort);
07/01/1999-12/31/2004 ($1,350,000 total direct costs).
Michigan Life Sciences Initiative
“Novel Strategy for Mucosal Vaccine Development”
P.I.: Ellen Zimmerman, M.D.
Role: Co-investigator (5% effort)
01/01/2001-12/31/2003($327,321 annual direct costs)
NHLBI, R01 HL059823
“Cytokine control of host susceptibility to Pneumocystis”
P.I.: James M. Beck, M.D.
Role: Co-Investigator (10% effort)
9/30/1997-8/31/2002 ($1,000,000 direct costs).
Department of Veterans Affairs Merit Review Award (renewal years 09-13), “Recruitment and Activation of Pulmonary Lymphocyte Subsets”
P.I.: Jeffrey L. Curtis, M.D. (35% effort)
10/1/97-9/30/02($398,000 direct costs)
NIH/NHLBI, R01 HL061577
“T cell adhesion molecules in murine lupus pneumonitis”
P.I.: Jeffrey L. Curtis M.D. (20% effort)
12/1/1998-11/30/2002 ($873,904 direct costs)
Novartis Protocol CFOR258D US06
“A randomized, multicenter, open-label, parallel group study comparing the efficacy and safety of Foradil® Aerolizer (formoterol fumarate inhalation powder) 12 µg B.I.D. to Serevent® MDI (salmeterol xinafoate) 50 µg B.I.D. in patients with COPD”
P.I.: Jeffrey L. Curtis, M.D. (1% effort)
3/30/2002-10/30/2003
Pfizer Protocol #A0661087
“A randomized, multicenter, third-party blinded study comparing the efficacy and safety of Zithromax® (Azithromycin) for 3 days (1.5 grams) versus Avelox® (Moxifloxacin Hydrochloride) for 5 days (2.0 grams) in the outpatient treatment of acute exacerbations of chronic bronchitis (AECB)”;
P.I.: Jeffrey L. Curtis, M.D. (1% effort)
01/01/2002-12/31/2002
Honors and Awards
1969National Merit Scholarship, semi-finalist
1969 - 1973Presidential Scholarship (Full Tuition); University of Scranton
1969Scholar-Athlete Award, University of Scranton
1973B. S., Magna cum laude, University of Scranton
1983 - 1985Research Fellowship; American Lung Association
1987 Parker B. Francis Fellowship in Pulmonary Research
(declined to accept VA Career Development Award)
1988Edward Livingston Trudeau Scholar Award; American Lung Association (declined to accept VA Career Development Award)
1988 - 1990Research Associate, Career Development Program, Dept. of Veterans Affairs
1995Pulmonary Faculty & Staff Appreciation Award
1996 - 1999Career Investigator Award, American Lung Association of Michigan
1999Margaret Epp Weber Provider of Choice Award, VISN 11, Dept. of Veterans Affairs
2010Federal Employee of the Year Award, Federal Executive Board for Southeast Michigan.
2010Administrative Excellence Award, Pulmonary Fellowship.
Memberships in Professional Societies
1985 - presentAmerican Association for the Advancement of Science (AAAS)
1993 - presentAmerican Association of Immunologists (AAI)
1983 - 1994American College of Chest Physicians (ACCP)
1989elected Fellow
1980 - 2009American College of Physicians (ACP)
1989elected Fellow
1989 - 1995American Society for Cell Biology (ASCB)
1984 - presentAmerican Federation for Medical Research (AFMR)
1983 - presentAmerican Thoracic Society (ATS)
1993 - presentCentral Society for Clinical Research (CSCR)
1983 - 1990California Thoracic Society (CTS)
1998 - presentEuropean Respiratory Society
1997 - presentMichigan Thoracic Society (MTS)
1994 - presentNational Association of VA Physicians & Dentists (NAVAPD)
1987 - presentPhysicians for Social Responsibility (PSR)
1988 - 2000Leadership Circle
2000 - presentSociety for Leukocyte Biology
Editorial Positions, Boards, and Peer-Review Service
Editorial Board
2009-presentAmerican Journal of Respiratory & Critical Care Medicine
Ad Hoc Reviewer (alphabetical by journal)
1999American Journal of Medicine
1993-6, 2003-4
2008-2013American Journal of Pathology
1995, 2003-4,
2006-07American Journal of Physiology: Lung Cell & Molecular Biology
1989, 91,
1993-2013American Journal of Respiratory Cell & Molecular Biology
1988, 1991-4
1997-98, 2001-13American Review of Respiratory Diseases /American Journal of Respiratory & Critical Care Medicine
2000Anatomic Record
1988, 1996Annals of Internal Medicine
1996, 2005-7Blood
2008BMC Infectious Diseases
2010Clinical & Experimental Immunology
2006-2012CHEST
2002Circulation Research
2009COPD
2006, 2009-11
2013European Respiratory Journal
2005Experimental Haematology
1997, 2008Experimental Lung Research
2008Frontiers in Bioscience
2008Immunological Letters
2010Inflammation Research
2007-08International Journal of COPD
2009International Journal of Medicine & Medical Sciences
1989, 1994, 1998
2002–2005,
2007-13Journal of Clinical Investigation
1992, 95,
1997-2011Journal of Immunology
2009Journal of Innate Immunity
2000Journal of Infectious Diseases
2013Journal of Interferon & Cytokine Research
1997Journal of Investigative Medicine
1988, 1994-1995Journal of Laboratory & Clinical Medicine
1994, 1999-00,
2003-4, 2008-09
2011Journal of Leukocyte Biology
1996Lung
2011-12Molecular Medicine
2012Mucosal Immunity
2006Oncogene
2012PLOS One
2007Proceedings of the American Thoracic Society
1993Regional Immunology
2008-12Respiratory Research
1999The Lancet
2007, 2009-10Thorax
Study Sections
1988 - 1989Ad hoc reviewer, Merit Review Committee, DVA.
1989Member, Peer Review Panel of Chemical Toxicology Projects, Department of Energy.
1991Ad hoc reviewer, Merit Review Committee, DVA.
1993Ad hoc reviewer, Research Advisory Group, DVA.
1993Ad hoc reviewer, Grayson-Jockey Club Research Foundation Grants.
1995 - 1996Ad hoc reviewer, Merit Review Committee, DVA.
1995 - 1997Member, Grant Review Board - American Lung Association.
1997 Ad hoc reviewer, Study Section Lung Biology and Pathology A (LBPA), Center for Scientific Review (CSR), NIH.
1998 Ad hoc reviewer, Alberta Heritage Foundation, Canada.
1998 - 2001Member, Respiration Study Section, Merit Review Board, DVA.
1999 Research Enhancement Award Program (REAP) review board, DVA.
2000 Ad hoc Reviewer, Health Excellence Fund Program, Louisiana State Board of Regents.
2000 - 2001Chair, Respiration Study Section, Merit Review Board, DVA.
2001 - 2002Ad hoc reviewer, Career Development Award Committee, DVA.
2002Ad hoc reviewer, National Health & Medical Research Council in Australia.
2002Member, Site visit review board, 2PO1 CA073743-06, University of Pittsburgh; Pittsburgh, PA; National Cancer Institute (NCI).
2003Member, Site visit review board, 2M01 RR000073-42, General Center for Clinical Research, UTMB Galveston, TX; National Center for Research Resources, NIH.
2003Member, Site visit review board, 1P01 HL075385-01; Baltimore, MD; National Heart Lung and Blood Institute (NHLBI), NIH.
2003Ad hoc reviewer (appeal), VA Merit Review Board.
2003Member, Site visit review board, 2PO1 CA073743-06 (appeal); NCI.
2003Ad hoc member, Council Subcommittee D (Clinical Studies); NCI.
2003Ad hoc reviewer, Intermediate Research Fellowship (Clinical Scientist), The Wellcome Trust, UK.
2004 - 2006Chair, Research Career Development Award Committee (CADE 1), DVA.
2005Ad hoc reviewer, Lung Cellular and Molecular Immunology (LCMI), CSR, NIH.
2005Ad hoc reviewer, Senior Research Fellowship, The Wellcome Trust, UK.
2005Ad hoc reviewer, Canadian Lung Association.
2005Member, Gulf War Syndrome Study Section, DVA.
2005 - 2006Ad hoc reviewer, Scientific Advisory Committee, American Thoracic Society.
2006Member, Special Emphasis Panel ZHL1 CSR-A(M1), Specialized Centers of Clinical Research (SCCOR) in Chronic Obstructive Pulmonary Disease, NHLBI/NIH.
2006Ad hoc reviewer, “Elise-Richter-Position” Fonds zur Förderung der wissenschaftlichen Forschung (Austrian Science Fund).
2006Ad hoc reviewer, Respiratory Integrative Biology and Translational Research (RIBT), NIH/CSR.
2006Ad hoc reviewer, Section 4, Cardiovascular Issues, Flight Attendants Medical Research Institute (FAMRI) Study Section.
2007 - 2009Member, BLRD/CSRD Non-Clinician Eligibility Review Board, DVA.
2007 - 2009Member, Data Safety Monitoring Board (DSMB), Specialized Centers of Clinical Research, Division of Lung Diseases, NHLBI, NIH.
2007 - 2011Member, Scientific Advisory Committee, American Thoracic Society.
2007Ad hoc reviewer, Research Career Development Award Committee
(CADE 1), DVA.
2007Member, review panel, 2P01 HL071659, Div. of Lung Diseases, NHLBI, NIH.
2008 - 2010Ad hoc reviewer, Programme Grant, The Wellcome Trust, UK.
2008Ad hoc reviewer, Clinical Research 2 Integrated Review Group Study Section, DVA.
2009Ad hoc member, Scientific Advisory Committee, Parker B. Francis Foundation.
2010Ad hoc reviewer, Gulf War Syndrome Study Section (SPLD1), DVA.
2010Member, Workgroup HLBP (25) 1, 1PO1 HL107226, Div. of Lung Diseases, NHLBI, NIH.
2010Ad hoc reviewer, LCMI, CSR, NIH.
2011Ad hoc reviewer, Project Grant, The Wellcome Trust, UK.
2011Member, review panel, ZHL1 CSR-S (F3), NHLBI, NIH.
2011Member, review panel, John B. Barnwell William S. Middleton Awards, DVA.
2012Ad hoc reviewer, Immunology Merit Review (IMMA)DVA.
2012Ad hoc reviewer, IRAP, CSR, NIH.
2012Ad hoc reviewer, European Research Council Immunity & Infection LS6 Advanced Grant Panel
Teaching
University of California San Francisco (selected)
1985Instructor, M2 Introduction to Clinical Medicine course.
1986Instructor, M2 Introduction to Clinical Medicine course.
1988Lecturer, “Interstitial lung disease: advances in immunopathogenesis”. Seventh Annual Recent Advances in Pulmonary & Critical Care Medicine.
1988Instructor, M2 Introduction to Clinical Medicine course.
1989Lecturer, “Endothelial cell activation during an experimental pulmonary immune response in mice”. Pulmonary Staff Research Conference, Cardiovascular Research Institute, San Francisco, CA.
1989Instructor, M2 Introduction to Clinical Medicine course.
1989Supervision of postdoctoral fellow in manuscript preparation: Elaine Imoto, M.D.
05/18/1989Lecturer, “Endothelial activation and lymphocyte recruitment to the lungs”. VA Care AIDS Research Conference; VAMC, San Francisco, CA.
1990Lecturer, “Hypersensitivity pneumonitis”. Occupational and Environmental Medicine Course, San Francisco, CA.
Ann Arbor Department of Veterans Affairs Health System
1990-1995Attending Physician, Internal Medicine Service, Ann Arbor Veterans Administration Medical Center, 1 month/year.
11/08/1990Lecturer, “Airway management”. Grand Rounds.
12/06/1990Lecturer, “Modes of mechanical ventilation”. Critical Care Staff Meeting.
01/14/1991Lecturer, “Pressure-support ventilation”. Critical Care Staff Meeting.
05/03/1994Lecturer, “Fundamentals of airway management”. Grand Rounds.
09/19/1995Lecturer, “Airway management”. Grand Rounds.
05/07/1996Lecturer, “Steroids in COPD”. Grand Rounds.
09/18/1996Lecturer, “Management of COPD exacerbations”. Ambulatory Care Medicine Group.
10/30/1996Lecturer, “Community-acquired pneumonia”. Ambulatory Care Medicine Group.
10/11/2006Lecturer, “On the horizon: new research on COPD pathogenesis & treatment at the AAVAHS”. Ambulatory Care Medicine Group.
Noon Medical Housestaff Conference, VA Medical Center
05/03/1994Lecturer, “Disseminated histoplasmosis”.
01/06/1999Lecturer, “How to think like a Critical Care Doc”.
01/12/1999Lecturer, “Basics of ventilator management”.
06/05/2000Lecturer, “Massive hemoptysis”.
12/18/2002Lecturer, “Thinking critically: holistic care of the critically ill patient”.
02/18/2004Lecturer, “COPD: time for a therapeutic change”.
06/02/2004Lecturer, “Community-acquired pneumonia in adults – 2004”.
08/18/2004Lecturer, “Thinking critically: holistic care of the critically ill patient”.
08/22/2004Lecturer, “Basics of ventilator management”.
11/03/2004Lecturer, “Thinking critically: holistic care of the critically ill patient”.
08/08/2005Lecturer, “Thinking critically: holistic care of the critically ill patient”.
08/22/2005Lecturer, “Community-acquired pneumonia in adults – 2005”.
08/02/2006Lecturer, “COPD: management in the VA setting”.
10/18/2006Lecturer, “Thinking critically: holistic care of the critically ill patient”.
06/06/2007Lecturer, “COPD: management in the VA setting”.
08/15/2007Lecturer, “What’s new in community-acquired pneumonia?: the 2007 IDSA/ATS guidelines”.
04/09/2009Lecturer, “Current concepts in COPD”
06/11/2009Lecturer, “Community-acquired pneumonia: IDSA/ATS guidelines”.
8/27/2009Lecturer, “Reducing mortality in community-acquired pneumonia (CAP)”.
12/9/2010Lecturer, “Reducing mortality in community-acquired pneumonia (CAP)”.
Medical Housestaff Noon Conferences, Department of Internal Medicine. UMHS
09/02/1992Lecturer, “Workup of the solitary pulmonary nodule”.
06/15/1994Lecturer, “Workup of the solitary pulmonary nodule”.
09/14/1995Lecturer, “Nosocomial pneumonia”.
10/19/1995Lecturer, “Idiopathic pulmonary fibrosis.
09/23/1996Lecturer, “Workup of the solitary pulmonary nodule”.
05/14/1998Lecturer, “How to think like a Critical Care Doc”.
05/08/2002Lecturer, “COPD management”.
02/13/2003Lecturer, “COPD, the silent killer”.
University of Michigan Medical School, M1 Class
1991-1992Preclinical Advisor, M1 student, Jared Levin.
04/29/1993Instructor, M1 Clinical Skills course (Pulmonary module).
03/10/1994Instructor, M1 Clinical Skills course (Pulmonary module).
02/16/1995Instructor, M1 Clinical Skills course (Pulmonary module).
Fall 1995Discussion Group Leader, M1 Introduction to the Patient (ITTP) course.
02/13/1996Instructor Chest exam M1 ITTP.
03/21/1996Instructor, M1 Breast & cardiac exam M1 ITTP.
05/02/1996Instructor, M1 ITTP final exam.
02/20/1997Instructor, Chest exam M1 ITTP.
03/20/1997Instructor, Neurology exam M1 ITTP.
04/22/1997Instructor, M1 ITTP final exam.
04/29/1997Instructor, M1 ITTP final exam.
10/30/1997M1 ITTP Small Group Leader
11/13/1997M1 ITTP Small Group Leader
01/13/2000Instructor, Chest exam M1 ITTP.
01/21/2000Instructor, Chest exam M1 ITTP.
10/04/2001Instructor, Chest exam M1 ITTP.
10/03/2002Instructor, Chest exam M1 ITTP.
University of Michigan Medical School, M2 Class
1991-1992Instructor, M2 Clinical Skills: Raj Makim and Emily Lin.
1992-1993Instructor, M2 Clinical Skills: Richard Fiscor-Jacobs and Scott Paluska.
1993-1994Instructor, M2 Clinical Skills: Gregory Lara and Rahel Gherbre.
1995-1996Instructor, M2 Clinical Skills: Wilmer Baalaoing and Michael Hong.
11/18/1994Lecturer, “Medical aspects of bronchogenic carcinoma”, M2 Introduction to the Patient Cardiothoracic core curriculum.
11/13/1995Instructor, Pulmonary Physical Diagnosis M2 ITTP.
11/09/1995Lecturer, “Medical aspects of bronchogenic carcinoma”, M2 Introduction to the Patient Cardiothoracic core curriculum.
11/11/1996Instructor, Pulmonary Physical Diagnosis M2 ITTP.
11/11/1996Small Group Leader, M2 Respiratory core curriculum.
11/15/1996Lecturer, “Bronchogenic carcinoma”, M2 Respiratory core curriculum.
11/18/1996Instructor, Pulmonary Physical Diagnosis M2 ITTP.
11/06/1997Lecturer, “Chronic Obstructive Pulmonary Disease”, M2 Respiratory core curriculum.
11/10/1997Instructor, Classic Pulmonary Physical Findings, M2 ITTP.
11/12/1997Instructor, Classic Pulmonary Physical Findings, M2 ITTP.
11/14/1997Lecturer, “Lung Cancer”, M2 Respiratory core curriculum.
11/14/1997Small Group Leader, M2 Respiratory core curriculum.
1997-1998Instructor, M2 Clinical Skills Course: Dennis Wu and Michael Evers.
11/08/1999M2 Respiratory Sequence, Small Group Leader
11/12/1999M2 Respiratory Sequence, Small Group Leader
University of Michigan Medical School, M3 Class
1992-1993Tutor: Lance Washington.
University of Michigan Medical School, M4 Class
03/23/1994Instructor, Problem Solving Session for Internal Medicine Subinterns, “Management of solitary pulmonary nodule”.
Research Conferences, Division of Pulmonary & Critical Care Medicine, UMHS
09/21/1990Lecturer, “Mechanisms of lymphocyte recruitment to the lungs”.
04/18/1991Lecturer, “Regulation of pulmonary inflammation by CD4 + T lymphocytes”.
05/21/1992Lecturer, “Anabasis: the lymphocyte’s march to the lungs”.
01/29/1993Lecturer, “Adhesion receptor phenotypes of pulmonary CD4+ T cell subsets”.
10/15/1993Lecturer, “Birth, life and death in the alveolar space: lymphocyte proliferation and apoptosis”.
08/12/1994Lecturer, “The Song of the wandering lymphocyte”.
01/24/1997Lecturer, “Rolling, Sticking, Diving: Adhesive interactions between lymphocytes and lung endothelial cells”.
02/13/1998Lecturer, “Regulation of lung lymphocyte numbers during pulmonary inflammation: lessons from a murine model system”.